冠状病毒疾病的临床过程 2019 C-19 在患有支气管切除症的患者中
Ebru Çakır Edis1, Aykut Çilli2, Deniz Kızılırmak3
1Department of Pulmoner Medicine, Trakya University Faculty of Medicine, Edirne, Türkiye.
Thoracic research and practice
|October 25, 2024
概括
患有严重支气管切除症的患者,特别是囊性类型的患者,更有可能患上COVID-19. 然而,这些因素并不能预测支气管切除症患者感染的严重程度.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 冠状病毒疾病2019 (COVID-19) 构成了全球健康挑战,慢性肺部疾病患者的严重程度增加.
- 有限的数据存在于COVID-19的结果,特别是在被诊断为支气管切除症的患者.
研究的目的:
- 为了调查COVID-19在患有支气管切除症的患者的临床过程.
- 为了确定影响COVID-19临床结果的因素,在这个患者群体.
主要方法:
- 利用了来自土耳其成人支气管病变数据库 (TEBVEB) 的数据,这是一个多中心注册表.
- 分析了2019年3月至2022年1月期间606名支气管切除症患者的COVID-19相关数据.
主要成果:
- 119名 (19.6%) 支气管切除症患者感染了COVID-19,经常出现并发症,囊性支气管切除症和更高的支气管切除症严重性指数得分.
- 大多数COVID-19患者 (68.9%) 被管理为门诊患者,较少需要住院 (22.7%) 或重症监护室 (8.4%) 的入院.
- 虽然年龄较大和男性性别显示出住院的趋势,但这些并没有达到统计学意义.
结论:
- 严重的支气管炎症,囊性支气管炎症和更严重的支气管炎症严重性指数与患COVID-19的风险增加有关.
- 这些特定的支气管切除症特征似乎与COVID-19感染本身的严重程度无关.
相关概念视频
COPD: Pathogenesis and Clinical Features
238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pneumonia II: Pathophysiology
225
The pathophysiology of pneumonia involves the following steps:
225
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


